ANVS Annovis Bio, Inc.: institutional ownership and insider trading
67 funds reported holding $25.6M of Annovis Bio, Inc. in their latest 13F filings; in Q2 2026 funds net bought $12.7M, with 15 new positions and 11 funds selling out; over the last 12 months insiders bought $4.30M and sold $0 on the open market.
Famous investors holding ANVS
- Renaissance Technologies (Renaissance Technologies): $1.86M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.08M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $942K, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $43.6K, 0.0% of the portfolio
Largest institutional holders of ANVS
- Empery Asset Management, LP — $4.47M
- MARSHALL WACE, LLP — $3.43M
- VANGUARD GROUP INC — $3.19M
- VANGUARD CAPITAL MANAGEMENT LLC — $3.06M
- TUDOR INVESTMENT CORP ET AL — $2.52M
- RENAISSANCE TECHNOLOGIES LLC — $1.86M
- TWO SIGMA INVESTMENTS, LP — $1.08M
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $1.05M
- CITADEL ADVISORS LLC — $942K
- Caption Management, LLC — $883K
Recent ANVS insider trades
- May 20, 2026: Hoffman Michael B bought 76,344 shares ($143K)
- Apr 2, 2026: Hoffman Michael B bought 713,800 shares ($1.50M)
- Dec 8, 2025: Hoffman Michael B bought 45,000 shares ($194K)
- Nov 24, 2025: Hoffman Michael B bought 39,200 shares ($160K)
5%+ owners
- Highbridge Capital Management, LLC: 6.1% (Schedule 13G, filed Aug 14, 2026)